Blood Chemistry Testing - Cost Per Reportable Result

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

W40M MRCO EUROPE

Contract Value

Not provided

Codes & Classification
Solicitation Number

W9114F-26-Q-A010

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Classification Code

6550

Additional Details
Set Aside

NONE

Place of Performance

ITALY

SourceSAM
The Medical Readiness Contracting Office-Europe has issued a solicitation (W9114F-26-Q-A010) seeking proposals for the provision of one automated chemistry analyzer and associated consumables to support the laboratory mission at the U.S. Army Health Clinic in Vicenza, Italy. This procurement is designed to ensure the clinic’s ongoing capability to perform hematology testing, with the contractor responsible for supplying all necessary equipment, reagents, consumables, controls, and maintenance services. The contract will be structured under a Cost Per Reportable Result (CPRR) Contract Line Item Number (CLIN) arrangement, meaning the contractor will be compensated based on the number of reportable test results delivered. The scope of this requirement encompasses the full lifecycle support of the analyzer, including the provision and servicing of all parts, equipment, and consumables required for uninterrupted laboratory operations. The contractor will be expected to deliver, install, and maintain the analyzer, as well as ensure a consistent supply of reagents and consumables throughout the contract period. All deliverables must meet the technical and operational standards necessary for reliable hematology testing in a clinical setting. The resulting award will be a Fixed-Price, Indefinite Delivery/Indefinite Quantity (IDIQ) contract. The contract will begin with a two-month phase-in period from January 2, 2026, through February 28, 2026, followed by a single ordering period extending from March 1, 2026, to December 31, 2030. This structure is intended to provide flexibility in ordering and ensure sustained support for the clinic’s laboratory mission over several years. This solicitation is classified under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing), with a size standard of 1,250 employees, and Product Service Code 6550. The procurement is open to full and open competition, with no set-aside restrictions, inviting participation from all qualified vendors regardless of business size. The place of performance is Vicenza, Italy. The evaluation of proposals will follow Simplified Acquisition Procedures and utilize the Lowest Price Technically Acceptable (LPTA) methodology. Offerors must ensure strict compliance with the Instructions to Offerors as outlined in the solicitation documents. All vendors must be registered in the System for Award Management (SAM) prior to submitting a response; failure to register will render a quotation ineligible for award. Offerors are required to complete all relevant sections of the Standard Form (SF) 1449 and acknowledge any amendments as specified. The contracting entity for this opportunity is W40M MRCO EUROPE, a federal office responsible for medical readiness contracting in the European theater. The primary point of contact for this solicitation is Elena Raspitha ([email protected], +49 6371 9464 4669), with Henning Mayer-Goldstein ([email protected], +49 6371 9464 6789) serving as the secondary contact. Interested parties are encouraged to review the full solicitation and associated attachments, available via the official SAM.gov opportunity page (https://sam.gov/opp/ab887258ebd94d249e42dc5ec79f2409/view), and to follow the notice for updates. The solicitation remains active, with a response deadline of January 12, 2025. This opportunity is well-suited for contractors with experience in supplying and supporting automated laboratory analyzers and consumables, particularly those familiar with U.S. government procurement processes and requirements for overseas medical facilities.
Documents7